IRRAS AB (publ) Share Price London S.E.
Equities
0GDW
SE0008321202
Medical Equipment, Supplies & Distribution
Sales 2023 * | 16Cr 1.56Cr 130.6Cr | Sales 2024 * | 25Cr 2.36Cr 196.71Cr | Capitalization | 18Cr 1.72Cr 143.85Cr |
---|---|---|---|---|---|
Net income 2023 * | -10Cr -95.74L -80Cr | Net income 2024 * | -2.9Cr -27.49L -23Cr | EV / Sales 2023 * | 2.38 x |
Net Debt 2023 * | 21Cr 2Cr 166.78Cr | Net Debt 2024 * | 26Cr 2.44Cr 204.08Cr | EV / Sales 2024 * | 1.77 x |
P/E ratio 2023 * |
-0.13
x | P/E ratio 2024 * |
-0.43
x | Employees | 47 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 3.55% |
Latest transcript on IRRAS AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Will Martin
CEO | Chief Executive Officer | 49 | 01/18/01 |
Griffen Stapp
DFI | Director of Finance/CFO | 38 | - |
Director/Board Member | 66 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marios Fotiadis
CHM | Chairman | 51 | 01/12/01 |
Director/Board Member | 66 | 01/15/01 | |
Director/Board Member | 69 | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
+14.31% | 13TCr | |
+1.11% | 1.2TCr | |
-20.95% | 688.26Cr | |
+56.86% | 686.18Cr | |
+9.27% | 346.77Cr | |
-15.62% | 254.4Cr | |
-18.25% | 189.98Cr | |
-27.00% | 157.83Cr | |
-38.19% | 143.01Cr |